During a nice dinner, where I met Marcos’ family, we discussed the idea to create a Society for Cardiovascular Pathology in a large continent like South America, similar to North America and Europe

Societies. The project has been interrupted by the early death of Marcos, but I hope that other Brazilian pathologists will honor this plan like his legacy. Marcos was born at Piracicaba, Sao Paulo, and belonged to an Italian family who selleck chemical had migrated to Brazil from Carrara, Tuscany, at the end of the XIX century. He wanted to keep both Brazilian and Italian citizenships. He was deeply linked to his country in origin and used to come to Italy as often as possible. For various reasons we were unable to arrange a sabbatical year in Padua at the Institute of Morgagni at my University, where Modern Medicine was born in XVI–XVIII Gemcitabine clinical trial centuries, a matter I deeply regret because I know it was his dream. Marcos Rossi made novel and important contributions in the field of experimental cardiovascular pathology, particularly tropical pathology. He was a generous, enthusiastic person. A great teacher, he supervised hundreds of graduate students in Medicine, residents in Pathology and Master and PhD candidates. A very important aspect

of his career is that, being a scientist in a developing country, he devoted much time to the dissemination of scientific knowledge and improvement of high research. Most of his scientific work has been accomplished in his country, by consolidating unless experimental pathology and cardiovascular pathology and influencing many laboratories and scientists all over Brazil. Arrivederci, Maestro! “
“In the article, “Altered collagen expression in jugular veins in multiple sclerosis” by Coen et al (Cardiovascular Pathology 2013;22(1):33-8), the correct affiliation for Fabrizio Salvi is: IRCCS Istituto delle Scienze Neurologiche, Ospedale Bellaria,

Bologna, Italy (IRCCS Institute of Neurological Sciences Bellaria Hospital, Bologna, Italy). “
“The journal Neurobiology of Stress was launched to address the needs of an expanding group of researchers investigating the neural inhibitors underpinnings of the stress response, neural plasticity and adaptation as consequences of stress and the translation of these consequences to neuropsychiatric disease in humans. This growth of stress research was driven by an increased realization that exposure to adverse events is causal to many chronic debilitating neuropsychiatric diseases. The significance of stress in human disease becomes magnified when considering evidence that it bridges neurobehavioral symptoms with peripheral symptoms such as obesity, irritable bowel and immune dysfunction, resulting in the complex medical-psychiatric co-morbidities that have become prevalent in our society.